1Kvols LK. Radiation sensitizers: A selective review of molecules targeting DNA and non-DNA targets. J Nucl Med,21 (4) :2005: 187s-190s.
2Okunieff P, Meyn RE, Teicher B, et al. Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003. Am J Clin Oncol, 2003, 26(5):522-529.
3Cheng SH, Huang AT. Comments on concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a mist of mysterious results. J Clin Oncol, 2005,23(12) :2864-2865.
4Kaizumi W, Saigenji K, Nakamaru N, et al. Prediction of response to 5′-deoxy-5-fluorouridine (5′-DFUR) in patients with inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor. Oncology, 1999,56(3) :215-222.
5Bajetta E, Di Bartolomeo M, Stani SC, et al. Chemoradiothorapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients:results of a feasibility study. Int J Radiat Oncol Biol Plys, 1999,45 ( 2 ) :285-289.
6Blanquicett C, Gillespie GY, Nabors LB, et al. Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation . Mol Cancer Ther, 2002,1(12): 1139-1145.
7Rich TA, Shepard R. COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: esophagus, stomach, and pancreas. Am J Clin Oncol, 2003,26(4) :S110-S113.
8Lorvidhaya V, Chitapanarux I, Sangruchi S, et al. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial .Int J Radiat Oncol Biol Phys, 2003,55 ( 5 ): 1226 - 1232.
9Roberts KB, Urdaneta N, Vera R,et al. Interim results of a randomized trial of mitomycin c as an adjunct to radical radiotherapy in the treatment of locally advanced squamous- cell carcinoma of the cervix.Int J Cancer, 2000,90 (4) :206-223.
10Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aorticirradiation for highrisk cervical cancer: an update of radiation therapy oncology group trial (RTOG)90-01. J Clin Oncol, 2004,22(5) :827-880.
